Daniel Rotroff, PhD, discusses the investigation of biomarkers that could help identify patients with breast cancer who are at risk for developing chemotherapy-induced peripheral neuropathy.
Daniel Rotroff, PhD
Advertisement
Articles by Daniel Rotroff, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
2
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
3
Aglatimagene Besadenovec Plus EBRT Improves Prostate Cancer-Specific DFS
4
Hematologists Highlight Top Data From ASCO 2026
5